Arrowstreet Capital
ARCT icon

Arrowstreet Capital’s Arcturus Therapeutics ARCT Stock Holding History

Arrowstreet Capital’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-552,179
Closed -$10.2M – 1824
2025
Q3 		$10.2M Buy
552,179
+514,652
+1,371% +$8.27M 0.01% 947
2025
Q2 		$488K Buy
+37,527
New +$444K ﹤0.01% 1753
2024
Q2 		– Sell
-116,797
Closed -$3.94M – 1511
2024
Q1 		$3.94M Buy
116,797
+95,221
+441% +$3.37M ﹤0.01% 963
2023
Q4 		$680K Buy
+21,576
New +$513K ﹤0.01% 1175
2023
Q3 		– Sell
-127,244
Closed -$3.65M – 1241
2023
Q2 		$3.65M Buy
+127,244
New +$3.46M ﹤0.01% 693

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return